Option License Sample Clauses

Option License. Upon exercise of the Option by Intel as described in Section 3.5 above and subject to the terms of this Agreement, Intellon agrees to grant and hereby does grant to Intel a non-exclusive, non-transferable (except pursuant to Section 12.11), perpetual, worldwide, fully paid, royalty-free (or royalty-bearing, depending upon the circumstances described in Section 4.2 below) license, without the right to sublicense (but with have made rights as described and conditioned in Sections 4.1.2 and 4.4.1, respectively, below), under Intellectual Property rights in the Intellon HomePlug AV Design or portions thereof which Intellon owns or has authority to grant licenses of the scope set forth herein, to:
AutoNDA by SimpleDocs
Option License. With respect to each [ * ] as to which ImmunoGen notifies Millennium that an [ * ] is available in accordance with [ * ] of this Agreement (each, a "[ * ]"), ImmunoGen hereby grants to Millennium (a) a [ * ], with (i) an [ * ] and an (ii) [ * ], and (b) [ * ], during the term of the [ * ], to obtain an [ * ] in connection with the Millennium [ * ]. The [ * ] set forth in [ * ] of this [ * ] shall include the right to [ * ] of Millennium, [ * ] of [ * ] of Millennium, and [ * ] with respect to [ * ] Millennium [ * ] with the Millennium [ * ]. For purposes of clarity, the [ * ] set forth in this [ * ] shall include the right to access [ * ] in accordance with [ * ] hereof for the purpose of [ * ].
Option License. Subject to Sections 7.3 and 7.5, Silence, for itself and its Affiliates, hereby grants to AZ upon satisfaction of the conditions set forth in the last sentence of Section 6.1 in respect of a particular Selected Target, an exclusive (even as to Silence), royalty-bearing license, with the right to grant sublicenses as provided in Section 7.3, under the Silence Background IP, Silence Research IP, and Silence’s interest in the Joint Research IP to Exploit the Licensed Compounds and Licensed Products directed to such Selected Target in the Field in the Territory. For clarity, the license set out in this Section 7.1 includes a license to all Licensed Compounds in relation to which activities were performed under the applicable Research Plan, whether or not such Licensed Compounds were shown to meet the Development Candidate Criteria.
Option License. SUBLICENSES
Option License. Upon exercise of the Option by Intel as described in Section 3.5 above and subject to the terms of this Agreement, Intellon agrees to grant and hereby does grant to Intel a non-exclusive, non-transferable (except pursuant to Section 12.11), perpetual, worldwide, fully paid, [****] license, without the right to sublicense (but with have made rights as described and conditioned in Sections 4.1.2 and 4.4.1, respectively, below), under Intellectual Property rights in the Intellon HomePlug AV Design or portions thereof which Intellon owns or has authority to grant licenses of the scope set forth herein, to:
Option License 

Related to Option License

  • Option The Receiver hereby grants to the Assuming Institution an exclusive option for the period of ninety (90) days commencing the day after Bank Closing to accept an assignment from the Receiver of all Leased Data Management Equipment.

  • Stock Options With respect to the stock options (the “Stock Options”) granted pursuant to the stock-based compensation plans of the Company and its subsidiaries (the “Company Stock Plans”), (i) each Stock Option intended to qualify as an “incentive stock option” under Section 422 of the Code so qualifies, (ii) each grant of a Stock Option was duly authorized no later than the date on which the grant of such Stock Option was by its terms to be effective (the “Grant Date”) by all necessary corporate action, including, as applicable, approval by the board of directors of the Company (or a duly constituted and authorized committee thereof) and any required stockholder approval by the necessary number of votes or written consents, and the award agreement governing such grant (if any) was duly executed and delivered by each party thereto, (iii) each such grant was made in accordance with the terms of the Company Stock Plans, the Exchange Act and all other applicable laws and regulatory rules or requirements, including the rules of the New York Stock Exchange and any other exchange on which Company securities are traded, and (iv) each such grant was properly accounted for in accordance with GAAP in the financial statements (including the related notes) of the Company and disclosed in the Company’s filings with the Commission in accordance with the Exchange Act and all other applicable laws. The Company has not knowingly granted, and there is no and has been no policy or practice of the Company of granting, Stock Options prior to, or otherwise coordinating the grant of Stock Options with, the release or other public announcement of material information regarding the Company or its subsidiaries or their results of operations or prospects.

Time is Money Join Law Insider Premium to draft better contracts faster.